EUVIMEDEUVIMED entdecken
Open Access

Cognitive effects of long‐term androgen deprivation therapy in older men with prostate cancer

Denise Pergolizzi iD, Kathleen R Flaherty iD, Rebecca M Saracino iD, James C Root iD, Elizabeth Schofield, Caroline Cassidy, Vani Katheria, Sunita K Patel iD, William Dale, Christian J Nelson

Psycho-Oncology · 2024

DOI: 10.1002/pon.6336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psycho-Oncology, 2024. Verfasst von Denise Pergolizzi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health Sciences, Universitat Internacional de Catalunya (UIC), Barcelona, Spain. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Androgen deprivation therapy (ADT) is a common treatment for prostate cancer (PCa), with increasing numbers of men on ADT for longer. Limited evidence suggests ADT impacts cognition. This study addressed gaps in the literature by focusing on older men with PCa and assessing ADT usage longer than 1 year.

Methods

This study of 133 men ≥65 years of age with PCa included two groups: (1) men on ADT for 1–3 years (ADT‐exposed), and (2) a comparison group of men with PCa not on ADT (ADT‐unexposed). Group comparisons on individual neuropsychological test scores are reported, as well as effect sizes (Cohen's d ).

Results

Half ( n = 67) of the sample was ADT‐exposed and half ( n = 66) were unexposed. The average age was 72 years, most were White, and over 50% had at least secondary education. There were no statistically significant differences between groups by age, race, or education. Unadjusted analyses showed the ADT‐exposed group, compared with the ADT‐unexposed group, performed significantly lower in domains of verbal learning ( d = 0.45–0.52, p = 0.01 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMaleHumansAgedInfantChild, PreschoolAndrogen AntagonistsAndrogensCognition

Stichwörter der Autor:innen

androgen deprivation therapycancercognitionolder adultsoncologyprostate cancer

Substanzen

Androgen AntagonistsAndrogens

Autor:innen und Institutionen

  • School of Medicine and Health Sciences, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • City of Hope Comprehensive Cancer Center, Duarte, California, USA.

ORCID-Profile: Denise Pergolizzi, Kathleen R Flaherty, Rebecca M Saracino, James C Root, Sunita K Patel

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Pergolizzi, D., Flaherty, K. R., Saracino, R. M., Root, J. C., Schofield, E., Cassidy, C., Katheria, V., Patel, S. K., Dale, W., & Nelson, C. J. (2024). Cognitive effects of long‐term androgen deprivation therapy in older men with prostate cancer. Psycho-Oncology. https://doi.org/10.1002/pon.6336

Vancouver

Pergolizzi D, Flaherty KR, Saracino RM, Root JC, Schofield E, Cassidy C, et al. Cognitive effects of long‐term androgen deprivation therapy in older men with prostate cancer. Psycho-Oncology. 2024. doi:10.1002/pon.6336

BibTeX
@article{Pergolizzi2024,
  author = {Pergolizzi, Denise and Flaherty, Kathleen R and Saracino, Rebecca M and Root, James C and Schofield, Elizabeth and Cassidy, Caroline and Katheria, Vani and Patel, Sunita K and Dale, William and Nelson, Christian J},
  title = {Cognitive effects of long‐term androgen deprivation therapy in older men with prostate cancer},
  journal = {Psycho-Oncology},
  year = {2024},
  doi = {10.1002/pon.6336}
}
Kostenlos starten →